NCT04633837View on ClinicalTrials.gov

Examining the Effectiveness of a Connective Tissue Matrix Implant in Reducing Post-operative Pain and Narcotic After Outpatient Arthroscopic Shoulder Surgery

NATerminatedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 4, 2020

Primary Completion Date

November 7, 2021

Study Completion Date

November 7, 2021

Conditions
Arthroscopic Shoulder SurgeryPain, Postoperative
Interventions
DEVICE

Extracellular Matrix Graft Injectable Implant

The extracellular matrix injectable implant will serve as the intervention in this study.

Trial Locations (1)

46123

American Health Network, Avon

Sponsors

Collaborators (1)

CTM Biomedical
All Listed Sponsors
collaborator

CTM Biomedical

INDUSTRY

lead

Brian Badman

OTHER

NCT04633837 - Examining the Effectiveness of a Connective Tissue Matrix Implant in Reducing Post-operative Pain and Narcotic After Outpatient Arthroscopic Shoulder Surgery | Biotech Hunter | Biotech Hunter